Carera Pharma A/S: Financial statements 2024
CVR: 39913046
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Carera Pharma A/S (CVR 39913046) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 302,071 and a net result of DKK -500,690 compared with DKK -411,785 the year before. That is a decrease of 69.8% compared with the year before. Equity in the 2024 report amounted to DKK -3,592,080. The company had 2 employees in the financial year.
- Gross Profit
- DKK 302,071
- Profit/Loss
- DKK -500,690
- Equity
- DKK -3,592,080
- Total Assets
- DKK 986,247
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 302K | -501K | -3.6M | 2 |
| 2023 | - | 999K | -412K | -3.1M | 3 |
| 2022 | - | -318K | -2M | -2.7M | 7 |
| 2021 | - | 1.8M | -607K | -653K | 7 |
| 2020 | - | 2.6M | -278K | -46K | 10 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Carera Pharma A/S has published its annual report for 2023. Gross profit came to DKK 999,210, and the net result was DKK -411,785.
About Carera Pharma A/S
Carera Pharma A/S is a Danish company of the type Aktieselskab based in København S, founded in 2018. The company is registered under the industry Engroshandel med andre fødevarer. The company was previously named Yokoso A/S. The management consists of Zengwen Jia. The board consists of Chenglin Gu (chair), Chen Liu and Zengwen Jia. The company is owned by Zengwen Jia. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -417,453 and a net result of DKK -626,216 compared with DKK -500,690 the year before. Equity in the 2025 report amounted to DKK -4,218,297.